Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Vascular Solutions, Inc. (VASC): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?: Atrion Corporation (ATRI), Unilife Corp (UNIS)

Vascular Solutions, Inc. (NASDAQ:VASC) was in 9 hedge funds’ portfolio at the end of the fourth quarter of 2012. VASC has experienced an increase in activity from the world’s largest hedge funds in recent months. There were 7 hedge funds in our database with VASC holdings at the end of the previous quarter.

Vascular Solutions, Inc. (NASDAQ:VASC)In the financial world, there are tons of indicators shareholders can use to watch publicly traded companies. A couple of the best are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best fund managers can outpace the S&P 500 by a healthy margin (see just how much).

Just as important, positive insider trading sentiment is another way to break down the marketplace. Just as you’d expect, there are a variety of stimuli for an executive to cut shares of his or her company, but just one, very simple reason why they would buy. Many academic studies have demonstrated the valuable potential of this method if “monkeys” know where to look (learn more here).

Now, we’re going to take a gander at the latest action regarding Vascular Solutions, Inc. (NASDAQ:VASC).

Hedge fund activity in Vascular Solutions, Inc. (NASDAQ:VASC)

In preparation for this year, a total of 9 of the hedge funds we track were long in this stock, a change of 29% from the previous quarter. With the smart money’s capital changing hands, there exists an “upper tier” of key hedge fund managers who were increasing their holdings considerably.

Of the funds we track, Mario Gabelli’s GAMCO Investors had the most valuable position in Vascular Solutions, Inc. (NASDAQ:VASC), worth close to $5 million, accounting for 0% of its total 13F portfolio. Sitting at the No. 2 spot is Jim Simons of Renaissance Technologies, with a $2 million position; the fund has 0% of its 13F portfolio invested in the stock. Remaining peers with similar optimism include Robert B. Gillam’s McKinley Capital Management, Peter Algert and Kevin Coldiron’s Algert Coldiron Investors and John Overdeck and David Siegel’s Two Sigma Advisors.

Consequently, some big names have been driving this bullishness. McKinley Capital Management, managed by Robert B. Gillam, created the biggest position in Vascular Solutions, Inc. (NASDAQ:VASC). McKinley Capital Management had 1 million invested in the company at the end of the quarter. Richard Driehaus’s Driehaus Capital also made a $0 million investment in the stock during the quarter. The only other fund with a brand new VASC position is Joel Greenblatt’s Gotham Asset Management.

Insider trading activity in Vascular Solutions, Inc. (NASDAQ:VASC)

Bullish insider trading is most useful when the company in question has experienced transactions within the past half-year. Over the last 180-day time period, Vascular Solutions, Inc. (NASDAQ:VASC) has experienced zero unique insiders buying, and 4 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Vascular Solutions, Inc. (NASDAQ:VASC). These stocks are Atrion Corporation (NASDAQ:ATRI), Unilife Corp (NASDAQ:UNIS), Alphatec Holdings Inc (NASDAQ:ATEC), STAAR Surgical Company (NASDAQ:STAA), and OraSure Technologies, Inc. (NASDAQ:OSUR). This group of stocks belong to the medical instruments & supplies industry and their market caps resemble VASC’s market cap.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.